Search results for "human immunodeficiency virus"

showing 10 items of 174 documents

Aortic Stiffness in HIV Infection with and without Antiretroviral Therapy. A Meta-analysis of Observational Studies

2020

Background: The risk of Cardiovascular (CV) events is higher in HIV-infected patients (HIV+) compared to HIV-uninfected persons (HIV−). Large artery stiffness, a well-documented predictor of adverse CV prognosis, may mediate this enhanced risk. It is usually assessed by measuring aortic Pulse Wave Velocity (aPWV). Studies examining arterial stiffness in HIV+ yielded inconsistent results. We performed a meta-analysis with the aim to evaluate the association of HIV infection and its therapy [Antiretroviral Therapy (ART)] with aPWV. Design and Method: The Standardized Mean Difference (SMD) and corresponding 95% confidence intervals were calculated for aPWV in different comparison groups. Stati…

cardiovascular riskmedicine.medical_specialtySettore MED/09 - Medicina Internaaortic stiffnessSettore MED/17 - Malattie Infettivebusiness.industrypulse wave velocityHIV infection cardiovascular risk pulse wave velocity aortic stiffnessHuman immunodeficiency virus (HIV)virus diseasesSpecialties of internal medicineGeneral Medicinemedicine.disease_causeHIV infectionAntiretroviral therapyRC581-951Meta-analysisInternal medicineRC666-701MedicineDiseases of the circulatory (Cardiovascular) systemObservational studyAortic stiffnessbusinessPulse wave velocityArtery Research
researchProduct

Conductas de riesgo y actitudes relacionadas con la infección por vih/sida en hsh

2014

Abstract:The aim of this investigation is to analyze sexual risk behaviors and attitudes for HIV/AIDS infection of MSM. The ENSI was administrated to 202 men, 168 homosexuals and 24 bisexuals, from 14 to 57 years. The results show a high confidence in condoms as a method of HIV prevention (75.7% very effective and 28.1% effective); however the systematic use of a condom is moderate in anal intercourse (54.64%) and in vaginal intercourse (49.05%) and very low in oral sex (6.22%). There is a low perceived probability (20.28%) and moderate fear (41.25%) become infected with HIV. 20.3% report having drunk alcohol in the last relationship and 5.4% say other drugs. These results should be conside…

conductas de riesgolcsh:BF1-990Human immunodeficiency virus (HIV)vihmedicine.disease_causelaw.inventionDevelopmental psychology03 medical and health sciencesOral sexCondomAcquired immunodeficiency syndrome (AIDS)lawMedicine0501 psychology and cognitive sciencesSexual riskpreservativo030505 public healthbusiness.industry05 social sciencesmedicine.disease050106 general psychology & cognitive scienceshshlcsh:PsychologyAnal intercourse0305 other medical sciencebusinessDemographyINFAD
researchProduct

The implementation of pre-exposure prophylaxis in Spain without women

2018

El objetivo del presente artículo es la exposición sucinta de la exclusión de las mujeres en la resolución del 27 de Julio de 2017 en el que se explicita el convenio de colaboración entre la Dirección General de Salud Pública, Calidad e Innovación y la empresa Gilead Servicios S.L.U. Este convenio es la formalización de la entrada e implementación de la profilaxis preexposición ante el VIH en el territorio nacional. La profilaxis preexposición ante el VIH es una novedosa intervención biomédica de carácter preventivo aplicada en personas que no viven con el VIH, que contiene como parte fundamental la ingesta diaria de un medicamento llamado Truvada, formado por dos componentes farmacológicos…

medicine.medical_specialtyBiomedical interventionTenofovirDaily intakebusiness.industryPublic healthPreventionHuman immunodeficiency virus (HIV)virus diseasesVIHHIVExclusionMujeresEmtricitabinemedicine.disease_causeExclusiónPrePPrevenciónNursingMedicineWomenbusinessmedicine.drug
researchProduct

Molecular Surveillance of HIV-1 in Madrid, Spain: a Phylogeographic Analysis ▿

2011

ABSTRACT The molecular epidemiology of HIV-1 is constantly changing, mainly as a result of human migratory flows and the high adaptive ability of the virus. In recent years, Spain has become one of Europe's main destinations for immigrants and one of the western European countries with the highest rates of HIV-positive patients. Using a phylogeographic approach, we have analyzed the relationship between HIV-1 variants detected in immigrant and native populations of the urban area of Madrid. Our project was based on two coincidental facts. First, resistance tests were extended to naïve and newly diagnosed patients, and second, the Spanish government legislated the provision of legal status t…

medicine.medical_specialtyGenotypemedia_common.quotation_subjectImmunologyImmigrationMolecular Sequence DataHuman immunodeficiency virus (HIV)HIV InfectionsBiologyDestinationsmedicine.disease_causeMicrobiologylaw.invention03 medical and health sciences0302 clinical medicinePopulation GroupslawVirologyEpidemiologymedicinePrevalenceCluster AnalysisHumans030212 general & internal medicine030304 developmental biologymedia_commonTransients and Migrants0303 health sciencesMolecular EpidemiologyMolecular epidemiologySequence Analysis DNA3. Good healthPhylogeographyPhylogeographyTransmission (mechanics)Genetic Diversity and EvolutionSpainpol Gene Products Human Immunodeficiency VirusInsect ScienceCohortHIV-1Demography
researchProduct

Direct-acting antivirals for hepatitis C virus infections in patients co-infected with human immunodeficiency virus

2011

Summary Nearly three-quarters of human immunodeficiency virus–hepatitis C virus (HIV-HCV) coinfected patients in France currently need to be cured of their chronic HCV infection. The increase in sustained virological response rates obtained with the recently available HCV protease inhibitors in treatment-naive genotype-1 patients has generated considerable hope in these co-infected patients. However, several particularities (such as a higher baseline HCV load, more advanced liver fibrosis, frequent co-morbidities, and the risk of toxicity and drug–drug interactions) have not allowed the direct extrapolation of the results observed in HCV-monoinfected patients to patients with HIV-HCV co-inf…

medicine.medical_specialtyHepatitis C virusHuman immunodeficiency virus (HIV)HIV InfectionsContext (language use)medicine.disease_causeAntiviral AgentsViruschemistry.chemical_compoundPegylated interferonFibrosismedicineHumansIntensive care medicineHepatologybusiness.industryRibavirinGastroenterologyvirus diseasesHepatitis C Chronicmedicine.diseasechemistryImmunologyToxicitybusinessAlgorithmsmedicine.drugClinics and Research in Hepatology and Gastroenterology
researchProduct

Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients

2015

The aim of this review was to detail the current therapies and treatments for chronic hepatitis C virus in coinfected patients, focusing on HCV antiviral agents currently used in practice today or scheduled to enter the open market soon. Several direct-acting antiviral (DAA) combinations show high sustained virologic response (SVR) rates in HIV/HCV-coinfected patients, which are often close to those observed in HCV-monoinfected patients. Most recommendations regarding treatment stem from trials with coinfected patients. However, data are lacking for some aspects of HCV-treatment in coinfection, so extrapolations must be made from data obtained predominately from monoinfected patients. HIV/H…

medicine.medical_specialtyHepatitis C virusImmunologyPopulationHuman immunodeficiency virus (HIV)HIV Infectionsmedicine.disease_causeAntiviral AgentsVirusLiver diseaseChronic hepatitisVirologyInternal medicinemedicineHumansHiv infected patientsDrug Interactionseducationeducation.field_of_studyOncology (nursing)business.industryvirus diseasesHematologyHepatitis C Chronicmedicine.diseasedigestive system diseasesTreatment OutcomeInfectious DiseasesOncologyImmunologyCoinfectionDrug Therapy CombinationbusinessCurrent Opinion in HIV and AIDS
researchProduct

Epidemiological profile of patients infected by Human Immunodeficiency Virus (HIV)

2009

Introduction. The aim of the present work is to identify the principal characteristics of a sample of individuals at the moment of diagnosis of HIV infection. Material and methods. Descriptive, retrospective study, based on the hospital clinical records of 70 HIV+ patients, without AIDS, selected by means of simple aleatory sampling. Results. Transmission categories: Users of Injectable Drugs (UID) 81.4%, heterosexuals 10%, homo/bisexuals 4.3% and transfusions/plasma donors 2.9%, sex: ratio man/woman = 3.8/1, average age on diagnosis: 27.3 ± 7.0 years (UID 26.3 ± 5.1 years, heterosexuals 29.6 ± 2.1 years, homo/bisexuals 27.3 ± 3.9 and transfusions/plasma donors 51.4 ± 23.1 years (p = 0.02).…

medicine.medical_specialtyPediatricsSmoking habitbusiness.industryTransmission (medicine)Incidence (epidemiology)Human immunodeficiency virus (HIV)Retrospective cohort studyGeneral MedicineDiseasemedicine.diseasemedicine.disease_causeSurgeryAcquired immunodeficiency syndrome (AIDS)medicineMarital statusbusinessAnales del Sistema Sanitario de Navarra
researchProduct

Estudios de epidemiología molecular en población inmigrante en España

2014

Fundamentos: La epidemiología molecular es una nueva disciplina que permite la integración de la información sobre la variabilidad genética de patógenos infecciosos con su difusión en la población y subgrupos de la misma incluyendo, por ejemplo, las mutaciones de resistencia a antibióticos y antivirales. El objetivo es conocer qué posibles diferencias existe en las características genéticas de los agentes infecciosos que afectan a las poblaciones inmigrante y autóctoctona en España. Métodos: Se revisaron artículos originales publicados entre 1998-2013, con las palabras clave "epidemiología molecular", "tipado molecular", "secuenciación", "inmigrante", "España". Resultados: De un total de 26…

medicine.medical_specialtyResistencia a antibióticosPopulationHuman immunodeficiency virus (HIV)lcsh:Medicinemedicine.disease_causeInmigrantesHepatitisMycobacterium tuberculosisMolecular typingGenetic variationTuberculosisMedicineTypingeducationImmigrant populationGeneticseducation.field_of_studyMolecular epidemiologybiologybusiness.industrylcsh:Public aspects of medicinelcsh:REpidemiología molecularVIHlcsh:RA1-1270General Medicinebiology.organism_classificationSurgerybusinessRevista Española de Salud Pública
researchProduct

CD4saurus Rex & HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution.

2011

Abstract One of the most neglected areas of everyday clinical practice for HIV physicians is unexpectedly represented by CD4 T cell counts when used as an aid to clinical decisions. All who care for HIV patients believe that CD4+ T cell counts are a reliable method to evaluate a patient immune status. There is however a fatalistic acceptance that besides its general usefulness, CD4+ T cell counts have relevant clincal and immunological limits. Shortcomings of CD4 counts appear in certain clinical scenarios including identification of immunological nonresponders, subsequent development of cancer on antiretroviral teatment, failure on tretment simplification. Historical and recently described…

medicine.medical_specialtyT cellantiviral treatmentHuman immunodeficiency virus (HIV)lcsh:MedicineHIV; AIDS; CD4Diseasemedicine.disease_causeGeneral Biochemistry Genetics and Molecular BiologyCD4+T cellsImmune systemAcquired immunodeficiency syndrome (AIDS)medicineIntensive care medicineMedicine(all)clinical trialsImmune statusBiochemistry Genetics and Molecular Biology(all)business.industrylcsh:RCancerimmune reconstitutionGeneral Medicinemedicine.diseaseClinical trialmedicine.anatomical_structureImmunologyCommentarybusiness
researchProduct

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients

2013

Adverse drug reactions to highly antiretroviral therapy (HAART) are major obstacles in its success. Although overall mortality from HIV has dramatically declined owing to HAART, these antiretroviral regimens have been associated with a wide spectrum of severe cutaneous reactions. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. To optimize adherence and efficacy of antiretroviral treatment, clinicians must focus on preventing adverse effects whenever possible, and distinguish those that are self-limited from those that are potentially serious. This paper presents the case of a serious cutaneous adverse reaction to Atripla in a HIV-positive 50-…

medicine.medical_specialtybusiness.industryHuman immunodeficiency virus (HIV)Adverse drug reactionAdverse drug reactionsHIVDermatologylcsh:RL1-803medicine.disease_causeAntiretroviral therapyPublished online: May 2014Surgerylcsh:DermatologymedicineAntiretroviral treatmentSettore MED/35 - Malattie Cutanee E VenereeDrug reactionIntensive care medicinebusinessAdverse effectHighly antiretroviral therapySkin
researchProduct